Alcon Launches Ilevro, NSAID for Pain, Inflammation Associated With Cataract Surgery
Alcon, Laboratories, Inc., announced the launch of
Ilevro (nepafenac ophthalmic suspension), a new oncedaily
treatment option for pain and inflammation associated
with cataract surgery. In two double masked, randomized
clinical trials, nepafenac ophthalmic suspension
demonstrated superior clinical efficacy compared to ...